These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37652852)

  • 1. Pregnancy & neonatal outcomes in spondyloarthritis.
    Maguire S; Molto A
    Best Pract Res Clin Rheumatol; 2023 Sep; 37(3):101868. PubMed ID: 37652852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic controversies in spondyloarthritis: nonsteroidal anti-inflammatory drugs.
    Poddubnyy D; van der Heijde D
    Rheum Dis Clin North Am; 2012 Aug; 38(3):601-11. PubMed ID: 23083758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
    Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New evidence on the management of spondyloarthritis.
    Sieper J; Poddubnyy D
    Nat Rev Rheumatol; 2016 May; 12(5):282-95. PubMed ID: 27052489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
    Ward MM; Deodhar A; Akl EA; Lui A; Ermann J; Gensler LS; Smith JA; Borenstein D; Hiratzka J; Weiss PF; Inman RD; Majithia V; Haroon N; Maksymowych WP; Joyce J; Clark BM; Colbert RA; Figgie MP; Hallegua DS; Prete PE; Rosenbaum JT; Stebulis JA; van den Bosch F; Yu DT; Miller AS; Reveille JD; Caplan L
    Arthritis Rheumatol; 2016 Feb; 68(2):282-98. PubMed ID: 26401991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?
    Webers C; Kiltz U; Braun J; van der Heijde D; Boonen A
    Rheumatology (Oxford); 2023 Jun; 62(6):2139-2146. PubMed ID: 36205588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset ankylosing spondylitis and spondylarthritis: an update on clinical manifestations, differential diagnosis and pharmacological therapies.
    Toussirot E
    Drugs Aging; 2010 Jul; 27(7):523-31. PubMed ID: 20583847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
    Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
    Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriatic arthritis and spondyloarthritis assessment and management update.
    Mease P
    Curr Opin Rheumatol; 2013 May; 25(3):287-96. PubMed ID: 23492739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.
    Poddubnyy D; Haibel H; Braun J; Rudwaleit M; Sieper J
    Arthritis Rheumatol; 2015 Sep; 67(9):2369-75. PubMed ID: 26017497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network.
    Raiker R; Pakhchanian H; Kavadichanda C; Gupta L; Kardeş S; Ahmed S
    Clin Rheumatol; 2022 Mar; 41(3):721-730. PubMed ID: 34837569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are there new emerging drugs for ankylosing spondylitis or spondyloarthritis?
    Wendling D
    Expert Opin Emerg Drugs; 2013 Mar; 18(1):5-7. PubMed ID: 23216081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis.
    da Cruz Lage R; Marques CDL; Oliveira TL; Resende GG; Kohem CL; Saad CG; Ximenes AC; Gonçalves CR; Bianchi WA; de Souza Meirelles E; Keiserman MW; Chiereghin A; Campanholo CB; Lyrio AM; Schainberg CG; Pieruccetti LB; Yazbek MA; Palominos PE; Goncalves RSG; Assad RL; Bonfiglioli R; Lima SMAAL; Carneiro S; Azevedo VF; Albuquerque CP; Bernardo WM; Sampaio-Barros PD; de Medeiros Pinheiro M
    Adv Rheumatol; 2021 Jan; 61(1):4. PubMed ID: 33468245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal Antiinflammatory Drugs as Potential Disease-Modifying Medications in Axial Spondyloarthritis.
    Wang R; Bathon JM; Ward MM
    Arthritis Rheumatol; 2020 Apr; 72(4):518-528. PubMed ID: 31705611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological management of axial spondyloarthritis in adults.
    Toussirot E
    Expert Opin Pharmacother; 2019 Aug; 20(12):1483-1491. PubMed ID: 31095430
    [No Abstract]   [Full Text] [Related]  

  • 16. Axial spondyloarthritis: thoughts about nomenclature and treatment targets.
    Braun J
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S132-5. PubMed ID: 23079005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural disease modification in axial spondyloarthritis.
    Dinneen B; O'Shea F; Gensler L
    Best Pract Res Clin Rheumatol; 2023 Sep; 37(3):101898. PubMed ID: 38042689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
    Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
    Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agents.
    Toussirot E
    Expert Opin Pharmacother; 2017 Feb; 18(3):275-282. PubMed ID: 28099816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.
    Maksymowych WP; Inman RD; Gladman D; Thomson G; Stone M; Karsh J; Russell AS;
    J Rheumatol; 2003 Jun; 30(6):1356-63. PubMed ID: 12784417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.